Sarina A. Piha-Paul, Marc Ryan Matrana, Gagandeep Brar, Miguel Villalona-Calero, Shirly Grynberg, Jonathan Cohen, Yakir Rottenberg, Iwona A. Lugowska, Michael Jon Chisamore, Eric Keith Rowinsky, Guy Cinamon, Pini Tsukerman, Keren Paz. "Phase 1 study of NTX1088, a first-in-class anti-PVR monoclonal antibody, as monotherapy and combined with pembrolizumab, in patients with advanced solid malignancies.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.2518